Search
forResearch 4 of 38
- 44047 Long Term Real-World Treat-to-Target Skin Clearance and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry
- Generalized hypertrichosis due to secukinumab in a patient with moderate psoriasis: A case of serendipity or zemblanity?
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →